marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-18-2024
ADiTx Therapeutics Financial Ratios 2011-2024 | ADTX
Annual Financial Ratios ADiTx Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.0 | -0.0 | -0.0 | -2.8 | - | - | - | - | - | - | - | - | - |
P/S |
1.1 | 0.0 | 1.3 | - | - | - | - | - | - | - | - | - | - |
EPS |
-108.2 | -597.1 | -121.2 | -1.3 | -1.5 | - | - | - | - | - | - | - | - |
EV (Enterprise Value) |
29.2 M | 2.8 M | -1.25 M | 17.3 M | 2.97 M | 1.65 M | 84.9 K | - | - | - | - | - | - |
EBITDA per Share |
-84.8 | -540 | -109 | -1.28 | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
0.0 | -1.7 | - | - | - | - | - | - | - | - | - | ||
PEG |
- | 0.05 | - | - | - | - | - | - | - | - | - | ||
P/B |
0.0 | 0.0 | 0.0 | 2.3 | - | - | - | - | - | - | - | - | - |
P/CF |
-0.0 | -0.0 | -0.0 | -3.5 | - | - | - | - | - | - | - | - | - |
ROE % |
-201.67 | -531.08 | -455.48 | -83.09 | - | - | - | - | - | - | - | - | - |
ROA % |
-72.64 | -257.56 | -278.27 | -69.86 | - | - | - | - | - | - | - | - | - |
ROCE % |
-162.32 | -489.41 | -411.90 | -74.75 | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.6 | 1.9 | 2.6 | 9.0 | - | - | - | - | - | - | - | - | - |
DSO |
- | 17.6 | 156.1 | - | - | - | - | - | - | - | - | - | - |
DIO |
408.9 | 226.1 | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
408.9 | 243.7 | 156.1 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
408.9 | 243.7 | 156.1 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios ADiTx Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-111.07 | -4.19 | -9.14 | - | -1950.94 | -36.79 | -52.46 | - | -210.93 | -6.42 | -6.8 | - | -28.08 | -0.42 | -0.46 | - | -0.37 | -0.14 | -0.3 | - | -0.28 | -0.67 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-39.4 | -3.23 | -7.07 | - | -1.57 K | -26.7 | -49.7 | - | -148 | -6.22 | -6.75 | - | -16.7 | -0.39 | -0.44 | - | -0.37 | -0.1 | -0.27 | - | -0.28 | -0.66 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-301.16 | 206.32 | 468.15 | -8410.58 | -8470.11 | -8764.46 | -9341.16 | -617.67 | -692.91 | -708.62 | -382.38 | -234.95 | -259.88 | -209.56 | -110.81 | -40.58 | -2.70 | 60.11 | 154.57 | 193.63 | 193.63 | 155.75 | 66.14 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-242.83 | -320.29 | -371.59 | -276.82 | -316.22 | -235.11 | -211.68 | -145.26 | -195.09 | -205.52 | -189.90 | -124.09 | -145.05 | -116.17 | -81.40 | -34.12 | -908.71 | -1762.35 | -3827.35 | -2943.67 | -2943.67 | -2069.08 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-115.20 | 176.33 | 376.78 | -8193.10 | -8235.58 | -8469.81 | -9003.28 | -596.03 | -642.85 | -647.18 | -319.98 | -197.24 | -222.16 | -200.27 | -107.06 | -38.14 | -0.28 | 62.51 | 155.73 | 127.46 | 127.46 | 89.60 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.2 | 1.3 | 1.5 | 1.6 | 0.7 | 0.7 | 1.0 | 1.9 | 3.0 | 1.1 | 1.7 | 2.6 | 3.0 | 1.6 | 2.7 | 6.3 | 6.3 | 6.3 | 6.3 | 0.0 | 0.0 | 0.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
5047.8 | 859.0 | 478.3 | - | 271.9 | 146.2 | 179.0 | - | 151.6 | 140.1 | 73.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
63.9 | 2343.5 | 948.8 | - | 800.8 | 250.2 | 243.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
175.1 | 2131.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
5111.6 | 3202.6 | 1427.1 | - | 1072.7 | 396.4 | 422.1 | - | 151.6 | 140.1 | 73.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
4936.5 | 1070.7 | 1427.1 | - | 1072.7 | 396.4 | 422.1 | - | 151.6 | 140.1 | 73.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency